BGB-3111-LTE1
Enrolling by invitation
Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies
BeOne Study ID
ClinicalTrials.gov ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents
Locations
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? No
No Study Documents